TRPV4 and age-related macular degeneration: For eyes with serous RD, such as central serous chorioretinopathy and age-related macular degeneration, intravitreal injection of a TRPV4 blocker could delay photoreceptor cell death until successful retinal reattachment by laser photocoagulation, photodynamic therapy, intravitreal injection of antivascular endothelial growth factor, or other treatments can be performed.